Reference health

Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19

https://doi.org/10.3201/eid2710.211538
CiteStamped reference-health badge
5/5 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 5 checked references that resolve
resolves10.1016/j.lanepe.2021.100164
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany
resolves10.1038/s41577-020-00431-9
A cocktail of antibodies for COVID-19 therapy
resolves10.1056/NEJMc2031364
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
resolves10.3201/eid2704.210183
Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy
resolves10.1016/j.xcrm.2021.100255
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
The 3 references without a DOI — listed, not checked
no DOI — not checkedUS Food and Drug Administration. Emergency use authorization (EUA) for bamlanivimab 700 mg and estevimab 1,400 mg IV administered together. Center for Drug Use and Evaluation (CDER), 2021 [cited 2021 Jul 22]. https://www.fda.gov/media/145802/download
no DOI — not checkedHensley MK, Bain WG, Jacobs J, Nambulli S, Parikh U, Cillo A, Intractable COVID-19 and prolonged SARS-CoV-2 replication in a CAR-T-cell therapy recipient: a case study. Clin Infect Dis. 2021;ciab072.
no DOI — not checkedEuropean Medicines Agency. Assessment report Eli Lilly. Company Limited use of bamlanivimab and etesevimab for the treatment of COVID-19, 2021 [cited 2021 Jun 2]. https://www.ema.europa.eu/en/documents/referral/eli-lilly-company-limited-antibody-combination-bamlanivimab/etesevimab-covid19-article-53-procedure-assessment-report_en.pdf
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.3201/eid2710.211538"><img src="https://citestamp.com/citestamped/10.3201/eid2710.211538/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.3201/eid2710.211538/badge.svg)](https://citestamp.com/citestamped/10.3201/eid2710.211538)